Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target
Abstract Frontotemporal Dementia (FTD) is a neurodegenerative disorder mainly characterised by Tau or TDP43 inclusions. A co-autoimmune aetiology has been hypothesised. In this study, we aimed at defining the pathogenetic role of anti-AMPA GluA3 antibodies in FTD. Serum and cerebrospinal fluid (CSF)...
Guardado en:
Autores principales: | B. Borroni, J. Stanic, C. Verpelli, M. Mellone, E. Bonomi, A. Alberici, P. Bernasconi, L. Culotta, E. Zianni, S. Archetti, M. Manes, S. Gazzina, R. Ghidoni, L. Benussi, C. Stuani, M. Di Luca, C. Sala, E. Buratti, A. Padovani, F. Gardoni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/06d950f123f848ba8e85a6894e3d8dd6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Prodromal frontotemporal dementia: clinical features and predictors of progression
por: Alberto Benussi, et al.
Publicado: (2021) -
GluA3-containing AMPA receptors: From physiology to synaptic dysfunction in brain disorders
por: Maria Italia, et al.
Publicado: (2021) -
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
por: Vincenzo Salpietro, et al.
Publicado: (2019) -
Homomeric GluA2(R) AMPA receptors can conduct when desensitized
por: Ian D. Coombs, et al.
Publicado: (2019) -
p97 regulates GluA1 homomeric AMPA receptor formation and plasma membrane expression
por: Yuan Ge, et al.
Publicado: (2019)